Aqua Bio Technology ASA: Hydrafacial has entered into partnership with Restorsea – Conversion Lab launches Veritas MD platform

Restorsea's commercialization of Aqua Bio Technologies ASA's hatching fluid
ingredient (Aquabeautine XL) continues.

As mentioned in the commercial update on November 26, 2020, Restorsea has
recently entered into two license agreements with two partners in addition to
the license agreement with NASDAQ-listed Conversion Labs.

In connection with Hydrafacial`s merger with Vesper Healthcare and the
contemplated listing on NASDAQ Capital Market
(https://www.businesswire.com/news/home/20201209005485/en/HydraFacial-an-
Experiential-Beauty-Health-Company-and-Vesper-Healthcare-Announce-Business-
Combination) (NASDAQ), Restorsea is presented as Hydrafacial's new partner from
2021 (https://2y7msb2elfoj22q7jr2xnc83-wpengine.netdna-ssl.com/wp-
content/uploads/2020/12/Project-Hydrate-Investor-Presentation_vFinal.pdf). In Q3
2020, Hydrafacial has 15,124 skincare machines in 87 countries.

As mentioned in the stock exchange announcement on 27 October 2020
(https://live.euronext.com/nb/listview/company-press-
release/146254#CompanyPressRelease-3402442), Restorsea has entered into an
agreement to license Aquabeautine XL to the company Conversion Labs, which was
listed on NASDAQ on 10 December 2020. Conversion Lab has today officially
launched its new Veritas MD telecommunications health platform, which will roll
out the new skincare brand Nava MD nationwide. Nava MD is based on Aquabeautine
XL.

The positive trend from Restorsea's commercialization of ABT's proprietary
technology increases the likelihood that ABT will receive additional renewal
payment and increased revenue from the sale of ingredients and royalties from
Restorsea and its licensees.

For further information, please contact Espen Kvale, CEO, telephone
+47 916 28 092

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
 ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Euronext Expand.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.